NCT06096779: A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis
- State
- Under way
- Phase
- Phase 2
- People
- 30 taking part
- Started
- 15 Jul 2024
- Primary completion
- 30 Jul 2027
- Arms
- Cohort A: Atezolizumab+Bevacizumab
- Results
- None posted
- 24 Oct 2023: Trial registered
- 15 Jul 2024: Trial started